MGO One Seven LLC Sells 180 Shares of SPDR S&P Biotech ETF $XBI

MGO One Seven LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.8% in the second quarter, Holdings Channel.com reports. The firm owned 4,502 shares of the exchange traded fund’s stock after selling 180 shares during the period. MGO One Seven LLC’s holdings in SPDR S&P Biotech ETF were worth $373,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of XBI. DHJJ Financial Advisors Ltd. bought a new stake in SPDR S&P Biotech ETF in the 2nd quarter valued at $25,000. Garrison Bradford & Associates Inc. bought a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at $39,000. Compass Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 46.0% in the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock valued at $51,000 after purchasing an additional 200 shares during the period. Golden State Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after purchasing an additional 319 shares during the period. Finally, Avalon Trust Co bought a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at $57,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $107.80 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $110.96. The firm has a fifty day moving average price of $96.06 and a two-hundred day moving average price of $86.64. The company has a market cap of $6.70 billion, a PE ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.